A question that not only concerns the legal department in the pharmaceutical world, but also the company’s information officer in relation to pharmaceutical advertising 💊. After all, the latest advertising material must always be in line with the latest case law.
Fortunately, there is the MEGRA information officer working group, which we were able to host in our office on Monday.
Of course, our IBs Natascha Gansinger and Mario Koller were also there. The exciting topic this time: ‘Judgements that every IB needs to know’.
Three court judgements were presented and extensively discussed over coffee and pastries. One point of the exciting afternoon was responsibilities.
💡 Did you know, for example, that in Austria the managing director is liable if an advertising medium is objected to? Although the IB must be reported to the authorities and check the scientific information of advertising material, the law states that the managing director is liable and not the IB.
👉 Therefore, the IB stands between (in the worst case) a fine and the management. One more reason not to regard the IB release as a necessary evil.
After the productive exchange, a few IBs went curling at the Schönbrunn Christmas market. They also had to prove their accuracy away from the advertising material control 😉